| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.097 | 0.05 |